NCT00294112 - Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 13, 2006

Primary Completion Date

July 21, 2006

Study Completion Date

July 21, 2006

Conditions

Crohn's Disease

Interventions

DRUG

Prochymal™ adult human mesenchymal stem cells

Cells in plasmalyte and containing dimethylsulfoxide

DRUG

adult human mesenchymal stem cells

two infusions, one week apart, each comprising adult human mesenchymal stem cells

Trial Locations (4)

Osiris Clinical Site, Pittsburgh

Osiris Clinical Site, Richmond

Osiris Clinical Site, Charlotte

Osiris Clinical Site, Baton Rouge